1. |
Interference with MEP50 inhibits HSP90 function and tumor development in NDRG2low adult T-cell leukemia. (ポスター,一般) 2023/09/22
|
2. |
Analysis of the constitutive activation of Jak/STAT signaling pathway through the loss of tumor suppressor gene NDRG2. (ポスター,一般) 2022/09/30
|
3. |
Development of the treatment for adult T cell leukemia/lymphoma (ATL) by highly polymerized proanthocyanidins from blueberry leaves. (口頭発表,一般) 2021/11
|
4. |
Development of the treatment for adult T cell leukemia/lymphoma (ATL) by highly polymerized proanthocyanidins from blueberry leaves. (口頭発表,一般) 2021/09
|
5. |
Novel tumor suppressor gene NDRG2 deficiency promotes metabolic disorders and liver cancer development. (口頭発表,一般) 2020/10
|
6. |
The activation of protein arginine methyltransferase PRMT5 promotes tumor development through Arginine methylation of HSP90A. (口頭発表,一般) 2020/09
|
7. |
PRMT5 inhibition is synthetic lethal with loss of NDRG2 through the suppression of HSP90A in ATL. (口頭発表,一般) 2019/10
|
8. |
Analysis of the molecular mechanism of metabolism and tumorigenesis through the loss of tumor suppressor gene NDRG2. (口頭発表,一般) 2019/09
|
9. |
The inhibition of EZH2 suppresses ATL development through the up-regulation of novel tumor suppressor gene NDRG2. (口頭発表,一般) 2019/09
|
10. |
がん抑制遺伝子NDRG2発現低下によるJak/STAT情報伝達系活性化機構. (口頭発表,一般) 2019/08
|
11. |
Overexpression of EZH2 confers ATL development through the suppression of tumor suppressor gene NDRG2. (口頭発表,一般) 2018/10
|
12. |
Arginine methylation of HSP90A by protein arginine methyltransferase PRMT5 promotes development of adult T-cell leukemia. (口頭発表,一般) 2018/09
|
13. |
アルギニンメチル化転移酵素PRMT5異常活性によるATL発症機構の解析. (口頭発表,一般) 2018/09
|
14. |
EZH2 overexpression in ATL promotes epigenetic silencing of tumor suppressor gene NDRG2. (ポスター,一般) 2018/07
|
15. |
Synthetic lethality of PRMT5 inhibition in NDRG2-deficient adult T-cell leukemia through HSP90A dysfunction. (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2017/09
|
16. |
新規がん抑制遺伝子NDRG2によるがん進展および転移の分子機構の解明. (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2017/09
|
17. |
Targeting PRMT5 inhibits HSP90A function with induction of tumor-specific apoptosis in NDRG2low ATL and other cancers. (ポスター,一般) 2017/03
|
18. |
アルギニンメチル化転移酵素PRMT5によるHSP90A活性調節機構. (口頭発表,一般) 2017/02
|
19. |
Loss of NDRG2/PP2A complex induces global abnormalities in protein phosphorylation in cancer development and progression. (口頭発表,一般) 2016/10
|
20. |
Molecular mechanism of a novel tumor suppressor gene NDRG2 expression regulation by HTLV1 infection. (口頭発表,一般) 2016/10
|
21. |
PTENリン酸化異常によるATL発症機構の解析. (口頭発表,一般) 2016/08
|
22. |
A novel tumor suppressor, NDRG2 is down-regulated by EZH2 overexpression through HTLV-1 infection in ATL cells. (ポスター,一般) 2016/07
|
23. |
Loss of NDRG2 enhanced activation of NF-κB pathway by PTEN and NIK phosphorylation for ATLL development. (口頭発表,一般) 2015/10
|
24. |
HTLV-1感染によるがん抑制遺伝子NDRG2発現調節機構の解析. (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2015/08
|
25. |
PTENリン酸化異常におけるATLがん発症機構. (口頭発表,一般) 2015/01
|
26. |
Ndrg2 deficient mice improve depressive behavior through the activation of AKT signaling. (口頭発表,一般) 2014/10
|
27. |
N-myc down-regulated gene 2 suppresses NF-κB as a PP2A recruiter for defending constitutive activation of NF-κB after HTLV-1 infection. (口頭発表,一般) 2014/09
|
28. |
NDRG2はPP2AリクルーターとしてPTEN及びNIK活性調節に関わる. (口頭発表,一般) 2014/02
|
29. |
Molecular mechanisms of 4-nitroquinoline 1-oxide(4-NQO)-induced oral carcinogenesis in NDRG2-deficient mice. (口頭発表,一般) 2013/10
|
30. |
NDRG2はPP2AリクルーターとしてPTEN及びNIK活性調節に関わる. (口頭発表,一般) 2013/08
|
31. |
がん抑制遺伝子NDRG2によるHTLV-1/Tax誘導性NFkappaB活性抑制機構の解析. (口頭発表,特別・招待講演等) 2012/09
|
32. |
情動や低酸素障害等、脳機能に対するストレス応答 がん抑制遺伝子NDRG2. (口頭発表,特別・招待講演等) 2012/03
|
33. |
T細胞特異的TSLC1 TgマウスはATL様の病態を示す. (口頭発表,一般) 2011/09
|
5件表示
|
全件表示(33件)
|